Newcastle University spin-out, AMLo Biosciences, has moved to The Biosphere, a specialist lab facility on Newcastle Helix.
The ground-breaking cancer diagnostics firm, formed in 2017, looks to save up to 2,000 lives each year with their prognostic test for early-stage skin cancer.
The company’s first product (AMBLor) will go to market in 2021, launching in the UK, USA and Australia. It has the potential to save up to 2,000 lives every year as well as reassure thousands of others that their early stage skin cancer will not progress.
The Biosphere building filled a historic gap in the supply of commercial laboratory space in Newcastle and is already home to other university spin outs, including Atelerix, Northern Accelerator’s first spin-out.
Newcastle University has a successful track record of innovative spin-out businesses that support the growth of the life science sector in the North East of England. And since the launch of Northern Accelerator the rate that spin-outs are created in the region has increased dramatically. The number of spin-out businesses from Northern Accelerator universities more than doubled over the past year and increased fivefold since the partnership began in 2016.
Dr Marie Labus, Chief Executive Officer of AMLo Biosciences, who has spent 16 years of her career leading research, product development and life science spin outs said:
“Too many people think you need to be based down south to be successful. We want to grow AMLo’s operations and international presence from Newcastle and play our part in creating jobs and opportunities for local people. We currently employ fewer than 10 people, but we have significant growth aims for our Newcastle office and laboratory. Our priority is to get AMBLor to market to help improve outcomes for melanoma patients and in the longer term we are looking to expand this product range for other cancers. We are delighted to join and help grow the life science sector in Newcastle.”
Luke Dunnett, Property Business Manager at The Biosphere, added:
“We are so proud that The Biosphere has become a hot spot for innovative new companies who are not only looking to make a difference in Newcastle, but across the world. Despite the uncertain environment, businesses have continued to innovate, with many of our tenants being awarded significant funding during lockdown to take their research forward. A huge welcome to ALMo Biosciences who will now be part of The Biosphere’s future success.”
For further information about AMLo Biosciences visit https://amlo-biosciences.com/
For more about Newcastle Helix visit https://newcastlehelix.com
